Analyst firms · Barclays · NTR

Barclays NTR price target and rating history

Nutrien Ltd. (NTR) · Industrials

Barclays rates Nutrien Ltd. (NTR) Overweight with a $85 price target, as of its latest action on Apr 27, 2026. It has published 7 rating actions on NTR since January 2022, including 2 upgrades and 2 downgrades. Across 11 firms with a NTR price target in the last 12 months, the median target is $80. Barclays's $85 is 6% above that.

Current rating
Overweight
Price target
$85
Median target, all firms
$80
Actions on NTR
7

Barclays price target on NTR

$116$86$562023202420252026
Barclays price target on NTR, each point a stated target, January 2022 to April 2026.

Every Barclays rating on NTR

How other firms rate NTR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
KeyBanc Capital MarketsSector WeightSep 11, 2026
National Bank FinancialSector Perform$77Aug 25, 2026
BNP Paribas ExaneOutperform$80Jul 28, 2026
JefferiesHold$63Jul 16, 2026
ScotiabankSector Outperform$80Jun 30, 2026
BerenbergHold$65Jun 10, 2026
Raymond JamesOutperform$90May 5, 2026
BofA SecuritiesBuy$82Apr 30, 2026
BarclaysOverweight$85Apr 27, 2026
UBSSell$67Mar 26, 2026
Wells FargoOverweight$100Mar 13, 2026
Morgan StanleyOverweight$77Jan 14, 2026

Questions about Barclays and NTR

What is Barclays's price target for NTR?
Barclays's latest stated price target for Nutrien Ltd. (NTR) is $85, from its action on Apr 27, 2026.
What is Barclays's rating on NTR?
Barclays rates NTR Overweight, a bullish rating, as of Apr 27, 2026.
When did Barclays last change its view on NTR?
On Apr 27, 2026, Barclays upgrades to Overweight from Equal Weight, price target $85.
How does Barclays's NTR target compare with other analysts?
Across 11 firms with a NTR price target in the last 12 months, the median target is $80. Barclays's $85 is 6% above that.

More NTR rating histories

All Barclays ratingsNTR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.